Skip to main content

Life sciences/Immunology/Immune disorders/Autoimmune disorders/Diabetes

A rare genetic mutation among the Berne Amish could shed light on human aging and life span.
A Georgetown University undergraduate working to develop the first microbial collection device of its kind was named the winner of the Lab to Launch competition, a new program created by AAAS to identify and support young technology innovators in the Washington, D.C., area.

The microbial array in the Yanomami villagers, the most diverse ever reported, includes bacteria with antibiotic-resistant genes.

AAAS CEO Alan I. Leshner hailed a U.S. judge’s ruling Wednesday that allows continued federal funding of embryonic stem cell research, saying it would allow “extremely promising” medical research to advance.

U.S. District Court Judge Royce Lamberth dismissed a lawsuit challenging federal funding of embryonic stem cell research, deferring to a ruling by the U.S. Court of Appeals that the research did not violate a federal law that bars the government from funding research that requires the destruction of embryos.